|
|
Thomson Financial Business Description:
| The Group's principal activities are to discover, develop, manufacture and market vaccines and antibody based biopharmaceutical products. The Group operates in two segments: Biopharmaceutical products and Antibody products. The Biopharmaceutical products segment includes the production and sale of proprietary biopharmaceutical products, as well as research and development efforts for the biopharmaceutical product line. The Antibody products segment includes the collection and sale of non-specific and specialty antibody products to other biopharmaceutical manufacturers, as well as the production and sale of antibody-body control and diagnostic products and laboratory testing services. The Group operates in the United States, South Korea, Israel and Canada. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Nabi Biopharmaceuticals
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
